At a glance
During this COCA Call, presenters will discuss post-COVID conditions (PCC), also referred to as Long COVID or post-acute sequelae of SARS-CoV-2 infection.
Overview
During this COCA Call, presenters will discuss post-COVID conditions (PCC), also referred to as Long COVID or post-acute sequelae of SARS-CoV-2 infection. Post-COVID conditions is an umbrella term for the wide range of health consequences that are present four or more weeks after infection with SARS-CoV-2. Of the variety of symptoms that patients with PCC experience, cardiovascular symptoms and complications are among the most common and debilitating. Presenters will also outline the recommended clinical approach to identifying and managing cardiovascular complications in these patients based on the American Academy of Physical Medicine and Rehabilitation's (AAPM&R) "Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Cardiovascular Complications in PCC". The burden of PCC is expected to reflect the disproportionate burden of infection by race, ethnicity, and socioeconomic status, and to highlight ongoing inequities in health care. The AAPM&R Health Equity Work Group has developed guidance to highlight the central role that principles of diversity, equity, and inclusion play in delivering quality health care.
Presenters
Miriam Nji, MD, MPH
Medical Epidemiologist
Post-COVID Conditions Team
Chronic Viral Diseases Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Jonathan Whiteson, MD, FAAPMR
Medical Director, Cardiac and Pulmonary Rehabilitation
Co-Director, NYU Post COVID Care Program
Rusk Rehabilitation, NYU Langone Health
Alba Azola, MD, FAAPMR
Assistant Professor
Co-director of the Post-Acute COVID-19 Team (JH PACT) Program
Department of Physical Medicine and Rehabilitation
Johns Hopkins University School of Medicine
Call Objectives
COCA Call Objectives
- Cite background information on the topic covered during the presentation.
- Discuss CDC's role in the topic covered during the presentation.
- Describe the topic's implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.
Activity-specific Objectives
- Describe cardiovascular symptoms and complications associated with post-COVID conditions.
- Determine which clinical assessments and tests are needed for a patient with cardiovascular symptoms.
- Apply health equity considerations to clinical care, activity management, and reconditioning of Long COVID patients.
Continuing Education
To receive continuing education (CE) for WC4520-092022 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Evaluating and Supporting Patients Presenting with Cardiovascular Symptoms Following COVID, Tuesday, September 20, 2022, please visit TCEO and follow these 9 Simple Steps by Monday, October 24, 2022.
To receive continuing education (CE) for WD4520-092022 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Evaluating and Supporting Patients Presenting with Cardiovascular Symptoms Following COVID, Tuesday, September 20, 2022, (Web on Demand), please visit TCEO and follow these 9 Simple Steps between Tuesday, October 25, 2022, and Friday, October 25, 2024.
In support of improving patient care, the Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 12/13/2023. PAs should only claim credit commensurate with the extent of their participation
CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.
CPE: The Centers for Disease Control and Prevention designated this (Knowledge-based) event for pharmacists to receive 0.1 CEUs in pharmacy education. JA-UANs: The Universal Activity Number is JA4008229-0000-22-114-L04-P and enduring is JA4008229-0000-22-115-H04-P.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program's validity or relevancy to the veterinary profession.
For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Target Audience
- Physicians
- Nurses
- Pharmacists
- Veterinarians
- Physician Assistants
- Health Educators
- Other Clinicians
Additional Information
- Contact Information: coca@cdc.gov
- Support/Funding: Centers for Disease Control and Prevention, Emergency Risk Communication Branch
- Method of Participation: You may participate in the educational activity by viewing the program information above.